 | • レポートコード：QAF27690 • 出版社/出版日：QYResearch / 2021年4月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のインフルエンザ用ワクチン市場について種類別（三価インフルエンザワクチン、四価インフルエンザワクチン）、用途別（子供用（6ヶ月〜3歳）、大人＆3歳以上子供用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・インフルエンザ用ワクチン市場の概要 ・世界の主要地域別インフルエンザ用ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のインフルエンザ用ワクチン市場規模2016-2021：種類別（三価インフルエンザワクチン、四価インフルエンザワクチン） ・世界のインフルエンザ用ワクチン市場予測2012-2027：種類別（三価インフルエンザワクチン、四価インフルエンザワクチン） ・世界のインフルエンザ用ワクチン市場規模2016-2021：用途別（子供用（6ヶ月〜3歳）、大人＆3歳以上子供用） ・世界のインフルエンザ用ワクチン市場予測2012-2027：用途別（子供用（6ヶ月〜3歳）、大人＆3歳以上子供用） ・インフルエンザ用ワクチンのアメリカ市場規模と予測2016-2021 ・インフルエンザ用ワクチンのヨーロッパ市場規模と予測2016-2021 ・インフルエンザ用ワクチンの中国市場規模と予測2016-2021 ・インフルエンザ用ワクチンの日本市場規模と予測2016-2021 ・インフルエンザ用ワクチンの東南アジア市場規模と予測2016-2021 ・インフルエンザ用ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi Pasteur、CSL、GSK、Mylan、Hulan Bio、AstraZeneca、CCBIO） ・インフルエンザ用ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インフルエンザ用ワクチンの市場動向・機会・課題 ・調査の結論 |
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The industry’s leading producers are Sanofi Pasteur, CSL and GSK, with revenue ratios of 44.94%, 25.37% and 14.70%, respectively, in 2019.
Market Analysis and Insights: Global Flu Vaccine Market
The global Flu Vaccine market was valued at US$ 5408 in 2020 and will reach US$ 7164.9 million by the end of 2027, growing at a CAGR of 4.8% during 2022-2027.
Global Flu Vaccine Scope and Market Size
The global Flu Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Flu Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
The Flu Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Flu Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
1 Flu Vaccine Market Overview
1.1 Flu Vaccine Product Scope
1.2 Flu Vaccine Segment by Type
1.2.1 Global Flu Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Vaccine Segment by Application
1.3.1 Global Flu Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Flu Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Flu Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Flu Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Flu Vaccine Price Trends (2016-2027)
2 Flu Vaccine Estimates and Forecasts by Region
2.1 Global Flu Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Flu Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Flu Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Flu Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Flu Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Flu Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Flu Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Flu Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Flu Vaccine Estimates and Projections (2016-2027)
2.4.3 China Flu Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Flu Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Flu Vaccine Estimates and Projections (2016-2027)
2.4.6 India Flu Vaccine Estimates and Projections (2016-2027)
3 Global Flu Vaccine Competition Landscape by Players
3.1 Global Top Flu Vaccine Players by Sales (2016-2021)
3.2 Global Top Flu Vaccine Players by Revenue (2016-2021)
3.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flu Vaccine as of 2020)
3.4 Global Flu Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Flu Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Flu Vaccine Market Size by Type
4.1 Global Flu Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Flu Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Flu Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Flu Vaccine Price by Type (2016-2021)
4.2 Global Flu Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Flu Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Flu Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Flu Vaccine Price Forecast by Type (2022-2027)
5 Global Flu Vaccine Market Size by Application
5.1 Global Flu Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Flu Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Flu Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Flu Vaccine Price by Application (2016-2021)
5.2 Global Flu Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Flu Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Flu Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Flu Vaccine Price Forecast by Application (2022-2027)
6 North America Flu Vaccine Market Facts & Figures
6.1 North America Flu Vaccine Sales by Company
6.1.1 North America Flu Vaccine Sales by Company (2016-2021)
6.1.2 North America Flu Vaccine Revenue by Company (2016-2021)
6.2 North America Flu Vaccine Sales Breakdown by Type
6.2.1 North America Flu Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Flu Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Flu Vaccine Sales Breakdown by Application
6.3.1 North America Flu Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Flu Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Flu Vaccine Market Facts & Figures
7.1 Europe Flu Vaccine Sales by Company
7.1.1 Europe Flu Vaccine Sales by Company (2016-2021)
7.1.2 Europe Flu Vaccine Revenue by Company (2016-2021)
7.2 Europe Flu Vaccine Sales Breakdown by Type
7.2.1 Europe Flu Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Flu Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Flu Vaccine Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)
8 China Flu Vaccine Market Facts & Figures
8.1 China Flu Vaccine Sales by Company
8.1.1 China Flu Vaccine Sales by Company (2016-2021)
8.1.2 China Flu Vaccine Revenue by Company (2016-2021)
8.2 China Flu Vaccine Sales Breakdown by Type
8.2.1 China Flu Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Flu Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Flu Vaccine Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Flu Vaccine Market Facts & Figures
9.1 Japan Flu Vaccine Sales by Company
9.1.1 Japan Flu Vaccine Sales by Company (2016-2021)
9.1.2 Japan Flu Vaccine Revenue by Company (2016-2021)
9.2 Japan Flu Vaccine Sales Breakdown by Type
9.2.1 Japan Flu Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Flu Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Flu Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Flu Vaccine Market Facts & Figures
10.1 Southeast Asia Flu Vaccine Sales by Company
10.1.1 Southeast Asia Flu Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Flu Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Flu Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Flu Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Flu Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Flu Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Flu Vaccine Market Facts & Figures
11.1 India Flu Vaccine Sales by Company
11.1.1 India Flu Vaccine Sales by Company (2016-2021)
11.1.2 India Flu Vaccine Revenue by Company (2016-2021)
11.2 India Flu Vaccine Sales Breakdown by Type
11.2.1 India Flu Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Flu Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Flu Vaccine Sales Breakdown by Application
11.3.1 India Flu Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Flu Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Flu Vaccine Business
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Corporation Information
12.1.2 Sanofi Pasteur Business Overview
12.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Pasteur Flu Vaccine Products Offered
12.1.5 Sanofi Pasteur Recent Development
12.2 CSL
12.2.1 CSL Corporation Information
12.2.2 CSL Business Overview
12.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CSL Flu Vaccine Products Offered
12.2.5 CSL Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Business Overview
12.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GSK Flu Vaccine Products Offered
12.3.5 GSK Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Flu Vaccine Products Offered
12.4.5 Mylan Recent Development
12.5 Hulan Bio
12.5.1 Hulan Bio Corporation Information
12.5.2 Hulan Bio Business Overview
12.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hulan Bio Flu Vaccine Products Offered
12.5.5 Hulan Bio Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Business Overview
12.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AstraZeneca Flu Vaccine Products Offered
12.6.5 AstraZeneca Recent Development
12.7 CCBIO
12.7.1 CCBIO Corporation Information
12.7.2 CCBIO Business Overview
12.7.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 CCBIO Flu Vaccine Products Offered
12.7.5 CCBIO Recent Development
…
13 Flu Vaccine Manufacturing Cost Analysis
13.1 Flu Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Flu Vaccine
13.4 Flu Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Flu Vaccine Distributors List
14.3 Flu Vaccine Customers
15 Market Dynamics
15.1 Flu Vaccine Market Trends
15.2 Flu Vaccine Drivers
15.3 Flu Vaccine Market Challenges
15.4 Flu Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Flu Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Flu Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Flu Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Flu Vaccine Sales (M Doses) by Region (2016-2021)
Table 5. Global Flu Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Flu Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Flu Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Flu Vaccine Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Flu Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Flu Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Flu Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Flu Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Flu Vaccine Sales Share by Company (2016-2021)
Table 14. Global Flu Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Flu Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flu Vaccine as of 2020)
Table 17. Global Flu Vaccine Average Price (US$/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Flu Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Flu Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Flu Vaccine Sales (M Doses) by Type (2016-2021)
Table 22. Global Flu Vaccine Sales Share by Type (2016-2021)
Table 23. Global Flu Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Flu Vaccine Price (US$/Dose) by Type (2016-2021)
Table 25. Global Flu Vaccine Sales Share by Type (2022-2027)
Table 26. Global Flu Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Flu Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Flu Vaccine Price (US$/Dose) by Type (2022-2027)
Table 29. Global Flu Vaccine Sales (M Doses) by Application (2016-2021)
Table 30. Global Flu Vaccine Sales Share by Application (2016-2021)
Table 31. Global Flu Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Flu Vaccine Price (US$/Dose) by Application (2016-2021)
Table 33. Global Flu Vaccine Sales (M Doses) by Application (2022-2027)
Table 34. Global Flu Vaccine Sales Share by Application (2022-2027)
Table 35. Global Flu Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Flu Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Flu Vaccine Price (US$/Dose) by Application (2022-2027)
Table 38. North America Flu Vaccine Sales (M Doses) by Company (2016-2021)
Table 39. North America Flu Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Flu Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Flu Vaccine Sales by Type (2016-2021) & (M Doses)
Table 43. North America Flu Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Flu Vaccine Sales by Type (2022-2027) & (M Doses)
Table 45. North America Flu Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Flu Vaccine Sales by Application (2016-2021) & (M Doses)
Table 47. North America Flu Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Flu Vaccine Sales by Application (2022-2027) & (M Doses)
Table 49. North America Flu Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Flu Vaccine Sales (M Doses) by Company (2016-2021)
Table 51. Europe Flu Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Flu Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Flu Vaccine Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Flu Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Flu Vaccine Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Flu Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Flu Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Flu Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Flu Vaccine Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Flu Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Flu Vaccine Sales (M Doses) by Company (2016-2021)
Table 63. China Flu Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Flu Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Flu Vaccine Sales by Type (2016-2021) & (M Doses)
Table 67. China Flu Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Flu Vaccine Sales by Type (2022-2027) & (M Doses)
Table 69. China Flu Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Flu Vaccine Sales by Application (2016-2021) & (M Doses)
Table 71. China Flu Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Flu Vaccine Sales by Application (2022-2027) & (M Doses)
Table 73. China Flu Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Flu Vaccine Sales (M Doses) by Company (2016-2021)
Table 75. Japan Flu Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Flu Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Flu Vaccine Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Flu Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Flu Vaccine Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Flu Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Flu Vaccine Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Flu Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Flu Vaccine Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Flu Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Flu Vaccine Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Flu Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Flu Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Flu Vaccine Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Flu Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Flu Vaccine Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Flu Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Flu Vaccine Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Flu Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Flu Vaccine Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Flu Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Flu Vaccine Sales (M Doses) by Company (2016-2021)
Table 99. India Flu Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Flu Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Flu Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Flu Vaccine Sales by Type (2016-2021) & (M Doses)
Table 103. India Flu Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Flu Vaccine Sales by Type (2022-2027) & (M Doses)
Table 105. India Flu Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Flu Vaccine Sales by Application (2016-2021) & (M Doses)
Table 107. India Flu Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Flu Vaccine Sales by Application (2022-2027) & (M Doses)
Table 109. India Flu Vaccine Sales Market Share by Application (2022-2027)
Table 110. Sanofi Pasteur Corporation Information
Table 111. Sanofi Pasteur Description and Business Overview
Table 112. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
Table 113. Sanofi Pasteur Flu Vaccine Product
Table 114. Sanofi Pasteur Recent Development
Table 115. CSL Corporation Information
Table 116. CSL Description and Business Overview
Table 117. CSL Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
Table 118. CSL Flu Vaccine Product
Table 119. CSL Recent Development
Table 120. GSK Corporation Information
Table 121. GSK Description and Business Overview
Table 122. GSK Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
Table 123. GSK Flu Vaccine Product
Table 124. GSK Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
Table 128. Mylan Flu Vaccine Product
Table 129. Mylan Recent Development
Table 130. Hulan Bio Corporation Information
Table 131. Hulan Bio Description and Business Overview
Table 132. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
Table 133. Hulan Bio Flu Vaccine Product
Table 134. Hulan Bio Recent Development
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
Table 138. AstraZeneca Flu Vaccine Product
Table 139. AstraZeneca Recent Development
Table 140. CCBIO Corporation Information
Table 141. CCBIO Description and Business Overview
Table 142. CCBIO Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
Table 143. CCBIO Flu Vaccine Product
Table 144. CCBIO Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Flu Vaccine Distributors List
Table 148. Flu Vaccine Customers List
Table 149. Flu Vaccine Market Trends
Table 150. Flu Vaccine Market Drivers
Table 151. Flu Vaccine Market Challenges
Table 152. Flu Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Flu Vaccine Product Picture
Figure 2. Global Flu Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Flu Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. For Children (6 months to 3 years) Examples
Figure 7. For Adults and Children over 3 years Examples
Figure 8. Global Flu Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Flu Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Flu Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 11. Global Flu Vaccine Price Trends Growth Rate (2016-2027) (US$/Dose)
Figure 12. Global Flu Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Flu Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Flu Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 16. Europe Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Flu Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Flu Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Flu Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Flu Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Flu Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Flu Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Flu Vaccine Players Market Share by Revenue in Flu Vaccine: 2016 & 2020
Figure 27. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Flu Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Flu Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Flu Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Flu Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Flu Vaccine Sales Market Share by Type in 2020
Figure 33. North America Flu Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Flu Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Flu Vaccine Sales Market Share by Application in 2020
Figure 36. China Flu Vaccine Sales Market Share by Type in 2020
Figure 37. China Flu Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Flu Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Flu Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Flu Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Flu Vaccine Sales Market Share by Application in 2020
Figure 42. India Flu Vaccine Sales Market Share by Type in 2020
Figure 43. India Flu Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Flu Vaccine
Figure 46. Manufacturing Process Analysis of Flu Vaccine
Figure 47. Flu Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
インフルエンザワクチンのグローバル市場2021 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…- 犬用インフルエンザワクチンのグローバル市場調査 2019年 The global Canine Influenza Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Canine Influenza Vaccine volume and value at global level, regional level and company level. From a global perspec…
- 馬用インフルエンザワクチンのグローバル市場調査 2019年 The global Equine Influenza Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Equine Influenza Vaccine volume and value at global level, regional level and company level. From a global perspec…
- 世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年） Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in…
- 肺炎球菌ワクチンのグローバル市場2021 Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015. The second place is Europe, following North America with sales market share over 18…